NCT00748579View on ClinicalTrials.gov

Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency

PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

July 31, 2009

Conditions
Heart Failure
Interventions
DRUG

CK-1827452

I.V. infusion for 0.5 hour at 54mg/hr followed by 1 hour at 21mg/hr

DRUG

CK-1827452

I.V. infusion for ≤ 1 hour at 72mg/hr followed by 1 hour at 36mg/hr

Trial Locations (3)

21205

Johns Hopkins Medical Institutions, Baltimore

84132

UUHSC / Division of Cardiology, Salt Lake City

M5G 1X5

Mount Sinai Hospital, Toronto

Sponsors

Lead Sponsor

Cytokinetics
All Listed Sponsors
lead

Cytokinetics

INDUSTRY

NCT00748579 - Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency | Biotech Hunter | Biotech Hunter